Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday,... ( PRINCETON N.J. June 4 /- Pharmass...)

Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th

Date:6/4/2008

PRINCETON, N.J., June 4 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) management will present at the Needham & Co. Biotechnology and Medical Technology Conference being held from June 11-12, 2008 at the New York Palace Hotel in New York, NY. Schaefer Price, Pharmasset's Chief Executive Officer, will provide an overview of the company on Wednesday, June 11, 2008 from 9:00 AM to 9:30 AM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm . Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm .

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevud
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
10. Pharmasset Appoints Herbert J. Conrad as a Director
11. Pharmasset Receives $10 Million of Working Capital

Post Your Comments:

(Date:6/18/2013)... Clara, CA (PRWEB) June 18, 2013 ... to standard size SEMs but have limited performance and ... lower resolution. Full size SEMs would normally provide better ... more knowledge to operate and have a higher cost ... address the gap between these two types of ...

(Date:6/18/2013)... 2013) A million electric cars could be on roads ... the help of research by the United States Department of ... , Professor Zhongwei Chen is part of a team led ... materials to replace the expensive platinum catalysts in fuel cells. ... fuel cells in vehicles is the cost of the units. ...

(Date:6/18/2013)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the fourth quarter and full year of ... Fourth Quarter of Fiscal 2013 Highlights , ... by 33.3% to RMB133.0 million ($21.4 million) from RMB99.8 ...

(Date:6/18/2013)... June 18, 2013 In support of ... the Consulate General of Switzerland in New York is ... Switzerland’s MS Tûranor PlanetSolar , to Manhattan. PlanetSolar ... DeepWater Expedition 2013 tour with scientists on board from ... Gérard d’Aboville, runs exclusively on energy from the sun ...

[0] Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes [0] US and Canadian researchers drive towards cheaper fuel cells for electric cars [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City

... a novel class of intracellular protein biologics, today ... of naturally occurring human supercharged proteins called Intraphilins. ... human proteins enable biologic drugs to penetrate and ... of proteins is the foundation of Permeon Biologics, ...

... form protein clumps in the body, then alarm bells ... associated with Alzheimer,s disease and type 2 diabetes, formerly ... proteins form clumps, then they might be able to ... Keller and his colleagues at the Helmholtz-Zentrum Dresden-Rossendorf and ...

... 2011 Gen-Probe Incorporated (NASDAQ: GPRO ) today ... total revenues of $135.9 million and non-GAAP earnings per share ... of APTIMA women,s health products in the second quarter of ... decline compared to strong sales a year ago," said Carl ...

Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs In the pursuit of dangerous clumps Gen-Probe Reports Financial Results for the Second Quarter of 2011

(Date:6/17/2013)... research published in Biochemical and Biophysical Research Communications ... can detect new, previously unknown viruses. The technique offers ... doctors have not identified a particular virus as the ... the new approach, scientists use blood serum as a ... advantage of the complete deciphering of the human genome, ...

(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...

(Date:6/17/2013)... . A new ... disease can be reversed with treatment. The study by researchers ... at McGill University and at Universit de Montral found that ... of mice with advanced Alzheimer,s disease (AD) recovers memory and ... Neuroinflammation in May, also suggest an underlying mechanism of ...

Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2 Saint Louis University researchers discover a way to detect new viruses 3 NIH fellowship helps researcher fight malaria, understand mosquito immunity 2 Blocking overactive receptor in Alzheimer's recovers memory loss and more 2

[0] Saint Louis University researchers discover a way to detect new viruses [0] NIH fellowship helps researcher fight malaria, understand mosquito immunity [0] Blocking overactive receptor in Alzheimer's recovers memory loss and more

... plants--is the most abundant biological material on Earth. ... plant-based biofuels research. Despite overwhelming interest, scientists know ... cellulose fibers. , However, recent work from the ... University describes the first real-time observations of cellulose ...

... of biomedical engineering at New Jersey Institute of Technology (NJIT) ... has received two grants that will help her bring the ... , Arinzeh received a $700,000 grant from ... agency that funds spinal cord research. She will use the ...

... When medics are treating trauma patients, every second counts. ... it difficult to locate veins and administer lifesaving drugs ... Institute of Technology researchers is developing an inexpensive, handheld ... quickly. , "Depth and angle are the critical ...

Cached Biology News:Formation of cellulose fibers tracked for the first time 2 NJIT engineer poised to take stem cell research a step forward 2 NJIT engineer poised to take stem cell research a step forward 3 Researchers develop portable 'vein finder' for faster, more accurate injections 2 Researchers develop portable 'vein finder' for faster, more accurate injections 3

Formation of cellulose fibers tracked for the first time NJIT engineer poised to take stem cell research a step forward Researchers develop portable 'vein finder' for faster, more accurate injections

... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...

... number is a new product number, ... number. If showing no availability yet, ... number (Z71,517-4) or contact customer service ... (expanded surface, easy grip) ...

... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...

... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ...

Biology Products:

Illumina Standard Data Analysis Report from Asuragen, Inc.CORNING 1700CM2 ROLLER BOTTLE, EASY GRIP CAP, GRADUATED, STERILE from Sigma-Aldrich CORNING ROLLER BOTTLES, 490 CM2, PS CAP, PLUG SEAL, STERILE from Sigma-Aldrich CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich